Table 3 Comparisons of characteristics between the intraretinal hemorrhage group and non-intraretinal hemorrhage group.

From: Influence of bevacizumab therapy and intraretinal hemorrhage in long-term outcomes of hemorrhagic retinal arterial macroaneurysm

Characteristics

IRH group

(n = 19)

Non-IRH group

(n = 27)

P-value

Age, years

77.8 ± 8.9

77.3 ± 7.8

0.858*

Male:female

7 (36.8%):12 (63.2%)

4 (14.8%):23 (85.2%)

0.159†

Diabetes mellitus

1 (5.3%)

2 (7.4%)

1.000†

Hypertension

13 (68.4%)

18 (66.7%)

0.901‡

Use of anticoagulants

4 (21.1%)

8 (29.6%)

0.735†

Blood pressure, mmHg

Systolic

136.8 ± 14.9

141.4 ± 16.9

0.515*

Diastolic

75.5 ± 11.3

76.5 ± 12.2

0.946*

Extent of hemorrhage, disc areas

10.7 ± 5.2

7.1 ± 4.3

0.019*

Presence of submacular hemorrhage

16 (84.2%)

9 (33.3%)

0.001‡

Treatment

  

0.887‡

Intravitreal bevacizumab

13 (68.4%)

19 (70.4%)

 

Observation

6 (31.6%)

8 (29.6%)

 

Follow-up period, months

22.6 ± 14.9

26.3 ± 15.9

0.371*

  1. Data are presented as mean ± standard deviation or number (%) where applicable.
  2. IRH intraretinal hemorrhage.
  3. *Statistical analysis was performed using Mann–Whitney U test.
  4. †Statistical analysis was performed using Fisher’s exact test.
  5. ‡Statistical analysis was performed using chi-square test.
Back to article page